Peru vs Tuvalu: Statin use vs. average non-HDL cholesterol levels

Peru
3.4
in 2018
Tuvalu
3.4
in 2018
Peru rank
75th
Tuvalu rank
75th

Statin use vs. average non-HDL cholesterol levels over time

  • Peru
  • Tuvalu
01234198019992018

How they compare

Peru currently reports 3.4 against 3.4 in Tuvalu, a difference of 0.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Peru ahead.

Peru ranks 75th and Tuvalu ranks 75th of 191 countries.

Across the 4 decades both report, Peru averaged higher in 1 and Tuvalu in 3.

Head to head by decade

Decade Peru Tuvalu Difference Ahead
1980s 3.59 3.57 0.02 Peru
1990s 3.6 3.78 0.18 Tuvalu
2000s 3.51 3.71 0.2 Tuvalu
2010s 3.44 3.53 0.0889 Tuvalu

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Peru or Tuvalu?
Peru, at 3.4 against 3.4 in Tuvalu as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Peru and Tuvalu?
0, with Peru ahead.
How many years of comparable data are there for Peru and Tuvalu?
39 years are reported by both, from 1980 to 2018.
How do Peru and Tuvalu rank globally for statin use vs. average non-hdl cholesterol levels?
Peru ranks 75th and Tuvalu ranks 75th of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.